US COVID-19 Death Toll Crosses 200,000
On September 22nd the United States death toll from the novel coronavirus crossed 200,000, with 6,884,032 confirmed infections.
Category: Other Infections
Other Infections
Latest
Other Infections
Latest
Increased Mortality Risk for COVID-19 Patients with Tuberculosis, HIV
A study of more than 22,000 people in South Africa found that patients with tuberculosis or HIV had a greater risk of death from COVID-19 compared to non-TB/non-HIV COVID-19 patients.
Other Infections
Popular
Montenegro Is Europe’s Last Remaining Coronavirus-free Country
Exactly how Montenegro, which has a population of 628,066 and close ties to Italy, has stayed coronavirus-free is not known.
HHS Cancels Remaining Order for 30,000 Philips Ventilators
HHS has terminated the remainder of its April 2020 contract with Philips for 43,000 EV300 ventilators to the Strategic National Stockpile.
Read More
Asthma May Not Be a Significant Risk Factor for Severe COVID-19 or COVID-related Intubation
COVID-19 patients with asthma did not seem to be more likely to be intubated than non-asthmatics, according to a new study.
Read More
Inflammation: The Key Factor That Explains Vulnerability to Severe COVID
The severity of COVID-19 can vary hugely. In some it causes no symptoms at all and in others it’s life threatening, with some people particularly vulnerable to its very severe impacts.
Read More
First Documented COVID-19 Reinfection, Immunity May Not Last
Hong Kong researchers announced that a man was reinfected with the novel coronavirus after 142 days, suggesting that immunity doesn’t last very long.
Read More
FDA Authorizes Convalescent Plasma for COVID-19
Convalescent plasma may be effective in lessening the severity or shortening the length of COVID-19 illness in some hospitalized patients, the FDA said.
Read More
COVID-19 Disproportionately Affects American Indians, Alaska Natives
In 23 selected states, the cumulative incidence of laboratory-confirmed COVID-19 cases among American Indians and Alaska Natives (AI/AN) was 3.5 times that of non-Hispanic whites.
Read More
COVID-19 Infection Risk 3.4 Times Greater for Healthcare Workers
Frontline healthcare workers had a 3.4-times greater risk of contracting the novel coronavirus compared to the general population.
Read More
Tradipitant May Accelerate Clinical Improvement in Patients with COVID-19 Pneumonia
According to interim analysis reported by Vanda Pharmaceuticals Inc, tradipitant — a neurokinin-1 receptor (NK-1R) antagonist — may accelerate clinical improvement in SARS-CoV-2 (COVID-19) pneumonia.
Read More
FDA Authorized Six Additional COVID-19 Tests This Week
As of Aug 13, 2020, the FDA has now authorized 213 COVID-19 tests under emergency use authorizations.EUAs, including 174 molecular tests, 37 antibody tests, and 2 antigen tests.
Read More
Inhaled Nitric Oxide: A Potential Treatment for Severe COVID-19?
Inhaled nitric oxide has been used to treat pulmonary hypertension and ARDS for decades. Now, research is emerging on positive outcomes for critical care COVID-19 patients who have been treated with iNO.
Read More
Russia COVID-19 Vaccine Reportedly Tested on Just 76 Humans
The COVID-19 vaccine, known as ‘Sputnik V’ and developed by the Gamaleya Research Institute in Moscow, has reportedly been tested in just 76 humans.
Read More
Industry Perspective: Inhaled Nitric Oxide Use for Patients with COVID-19
Two experts on inhaled nitric oxide explain the physiological effects and properties that make iNO a potential therapeutic agent in the battle against COVID-19.
Read More